Tue, Sep 16, 2014, 10:47 AM EDT - U.S. Markets close in 5 hrs 13 mins


% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • efficient_frontier2002 efficient_frontier2002 Feb 5, 2013 12:26 AM Flag

    Some Key Points from PropThink's SA Article

    1. 5 chemical reasons given for KERX obtaining an extension for its key patent.

    2. Besides, it has 2 other patents (until 2024 and 2026) which a generic would have to "invent around."

    3. Regardless, Europe (30% of Zenerex' market) will almost certainly give KERX 10 year exclusivity.

    4. The extremely strong anemia data may INCREASE Zenerex IP protection and protect it for DECADES.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.675-0.165(-1.19%)10:46 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.